Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
International Journal of Cancer|August 21, 2020
Cutaneous viral infections associated with ultraviolet radiation exposureYayi Zhao, Rossybelle P Amorrortu, Neil A Fenske, et al.
Nature Communications|June 16, 2016
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APCMichael J Schell, Mingli Yang, Jamie K Teer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 30, 2021
Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort StudyRossybelle P Amorrortu, Yayi Zhao, Jane L Messina, et al.
Cancer Research|July 16, 2021
Cutaneous Human Papillomaviruses and the Risk of Keratinocyte CarcinomasDana E Rollison, Rossybelle P Amorrortu, Yayi Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancerGerold Bepler, Charles Williams, Michael J Schell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumorsJhanelle E Gray, Eric Haura, Alberto Chiappori, et al.
Research Square|July 29, 2024
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Biological Research for Nursing|January 31, 2014
Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patientsRichard R Reich, Cecile A Lengacher, Kevin E Kip, et al.
Contemporary Clinical Trials|March 4, 2026
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center Clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|August 21, 2020
Cutaneous viral infections associated with ultraviolet radiation exposureYayi Zhao, Rossybelle P Amorrortu, Neil A Fenske, et al.
Nature Communications|June 16, 2016
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APCMichael J Schell, Mingli Yang, Jamie K Teer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 30, 2021
Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort StudyRossybelle P Amorrortu, Yayi Zhao, Jane L Messina, et al.
Cancer Research|July 16, 2021
Cutaneous Human Papillomaviruses and the Risk of Keratinocyte CarcinomasDana E Rollison, Rossybelle P Amorrortu, Yayi Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancerGerold Bepler, Charles Williams, Michael J Schell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumorsJhanelle E Gray, Eric Haura, Alberto Chiappori, et al.
Research Square|July 29, 2024
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Biological Research for Nursing|January 31, 2014
Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patientsRichard R Reich, Cecile A Lengacher, Kevin E Kip, et al.
Contemporary Clinical Trials|March 4, 2026
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center Clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Pageof 16